Terminal complement complex C5b-9 and C5b assay in sera of COVID-19 patients with different disease severities

Terminal complement complex C5b-9 and C5b assay in sera of COVID-19 patients with different disease severities

Objective: The aim of this study is to find out the link between the involvement of complement activation in the inflammatory reactions in COVID-19 patients, the deterioration of the clinical status and development of sever COVID-19 in those patients. Methodology: The study included 274 COVID-19 pat...

Bibliografiset tiedot
Päätekijät:	Asmaa Nasr El-Din, Kamal Ata
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	Zagazig University, Faculty of Medicine 2022-10-01
Sarja:	Microbes and Infectious Diseases
Aiheet:	key words: complement covid-19 c5b. c5b-9
Linkit:	https://mid.journals.ekb.eg/article_261883_a3edd5e4a63df2c2e4e6c70bfc4b4951.pdf

Samankaltaisia teoksia

Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention
Tekijä: Zvi Fishelson, et al.
Julkaistu: (2019-04-01)

Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species
Tekijä: Wioleta M. Zelek, et al.
Julkaistu: (2020-12-01)

Biomarkers of the Complement System Activation (C3a, C5a, sC5b-9) in Serum of Patients before and after Liver Transplantation
Tekijä: Marta Budkowska, et al.
Julkaistu: (2023-07-01)

Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
Tekijä: Guo-Qing Tang, et al.
Julkaistu: (2023-08-01)

Complement inhibition by anti-C5 antibodies - from bench to bedside and back again
Tekijä: Swiss Medical Weekly
Julkaistu: (2007-07-01)

Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
Tekijä: Guo-Qing Tang, et al.
Julkaistu: (2023-09-01)

Complement Proteins C5/C5a, Cathepsin D and Prolactin in Chondrocytes: A Possible Crosstalk in the Pathogenesis of Osteoarthritis
Tekijä: Sandeep Silawal, et al.
Julkaistu: (2022-03-01)

Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b
Tekijä: Ramon M. van den Bos, et al.
Julkaistu: (2019-09-01)

C5L2 CRISPR KO enhances dental pulp stem cell-mediated dentinogenesis via TrkB under TNFα-induced inflammation
Tekijä: Muhammad Irfan, et al.
Julkaistu: (2024-01-01)

Factor B and C4b2a Autoantibodies in C3 Glomerulopathy
Tekijä: Jill J. Hauer, et al.
Julkaistu: (2019-04-01)

Serum and plasma levels of Ba, but not those of soluble C5b-9, might be affected by renal function in chronic kidney disease patients
Tekijä: Ryoko Yamane, et al.
Julkaistu: (2023-02-01)

C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection
Tekijä: Valentin Goutaudier, et al.
Julkaistu: (2019-03-01)

The allosteric modulation of complement C5 by knob domain peptides
Tekijä: Alex Macpherson, et al.
Julkaistu: (2021-02-01)

C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases
Tekijä: Fei Zhao, et al.
Julkaistu: (2019-05-01)

Neuron and astrocyte specific 5mC and 5hmC signatures of BDNF’s receptor, TrkB
Tekijä: Xiaoran Wei, et al.
Julkaistu: (2024-08-01)

A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models
Tekijä: Melissa J. Benson, et al.
Julkaistu: (2015-04-01)

Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
Tekijä: Leon Cyranka, et al.
Julkaistu: (2023-11-01)

Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients
Tekijä: Rosa G. M. Lammerts, et al.
Julkaistu: (2019-10-01)

Assessment of Complement Cascade Components in Patients With Bipolar Disorder
Tekijä: Artur Reginia, et al.
Julkaistu: (2018-11-01)

Complement C3 inhibitor in patients with paroxysmal nocturnal hemoglobinuria with suboptimal response to C5 inhibitor therapy
Tekijä: M. V. Marchenko, et al.
Julkaistu: (2024-09-01)

Complement Anaphylatoxin C5a, Endothelial Dysfunction and Low-Grade Inflammation in Atherosclerotic Vascular Diseases
Tekijä: Gansuvd Shagdarsuren, et al.
Julkaistu: (2018-12-01)

Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives
Tekijä: Cristina Giorgio, et al.
Julkaistu: (2021-04-01)

A Novel Cleavage Pattern of Complement C5 Induced by Chlamydia trachomatis Infection via the Chlamydial Protease CPAF
Tekijä: Liang Peng, et al.
Julkaistu: (2022-01-01)

Complement C5a Implication in Axonal Growth After Injury
Tekijä: Aurélie Cotten, et al.
Julkaistu: (2024-10-01)

Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis
Tekijä: Haitao A. Wang, et al.
Julkaistu: (2017-06-01)

Editorial: The Role of Complement in Tumors
Tekijä: Barbara E. Rolfe, et al.
Julkaistu: (2020-02-01)

Differential Contributions of the Complement Anaphylotoxin Receptors C5aR1 and C5aR2 to the Early Innate Immune Response against Staphylococcus aureus Infection
Tekijä: Sarah A. Horst, et al.
Julkaistu: (2015-10-01)

New insights for C5a and C5a receptors in sepsis
Tekijä: Hongwei eGao, et al.
Julkaistu: (2012-12-01)

Complement C4A Regulates Autoreactive B Cells in Murine Lupus
Tekijä: Léa Simoni, et al.
Julkaistu: (2020-11-01)

Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines
Tekijä: Sára Kellnerová, et al.
Julkaistu: (2020-12-01)

Role of Murine Complement Component C5 in Acute in Vivo Infection by Pathogenic Leptospira interrogans
Tekijä: Íris A. de Castro, et al.
Julkaistu: (2018-03-01)

Using genetics to explore complement C5 as a druggable protein in periodontitis
Tekijä: Zoheir Alayash, et al.
Julkaistu: (2024-10-01)

Complement, but Not Platelets, Plays a Pivotal Role in the Outcome of Mucormycosis In Vivo
Tekijä: Verena Harpf, et al.
Julkaistu: (2023-01-01)

C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d
Tekijä: Daria Kowalska, et al.
Julkaistu: (2022-08-01)

Influence of complement protein C1q or complement receptor C5aR1 on gut microbiota composition in wildtype and Alzheimer’s mouse models
Tekijä: Tiffany J. Petrisko, et al.
Julkaistu: (2023-09-01)

Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5
Tekijä: Dennis J Doorduijn, et al.
Julkaistu: (2022-08-01)

Insights into the Complement System of Tunicates: C3a/C5aR of the Colonial Ascidian <i>Botryllus schlosseri</i>
Tekijä: Anna Peronato, et al.
Julkaistu: (2020-09-01)

Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages
Tekijä: Kai-Chen Wu, et al.
Julkaistu: (2023-03-01)

C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis
Tekijä: Quan-you Zheng, et al.
Julkaistu: (2019-08-01)

Dysregulated complement activation during acute myocardial infarction leads to endothelial glycocalyx degradation and endothelial dysfunction via the C5a:C5a-Receptor1 axis
Tekijä: Carl Vahldieck, et al.
Julkaistu: (2024-07-01)